Key result
Residual depressive symptoms after remission link to worse outcomes, requiring targeted antidepressant or adjunctive therapies.
Why the study?
Residual symptoms of depression are common even in patients meeting remission criteria and are associated with a worse prognosis, requiring identification and timely management.
Identifying and treating residual symptoms in depression is crucial for achieving full functional recovery and preventing relapse.
Attention to residual symptoms may aid recovery in depression; leaves open optimal strategies pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eva Češková (2020) conducted a review in Depressive disorder. Antidepressants was evaluated. Residual symptoms in depressive disorder are common even after remission and are associated with a worse outcome, necessitating targeted treatment strategies such as changing antidepressants or adjunctive medication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: